Showing results (21-30 of 308) with videos related to
Sort By:
Pageof 31
Journal of Cardiovascular Pharmacology and Therapeutics|January 16, 2007
Hypokalemia, cardiac failure, and reporting NXY-059 safety for acute strokeVictor L SerebruanyInternational Journal of Cardiology|April 30, 2016
Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?Victor Serebruany, Ales TomekDrugs of Today (Barcelona, Spain : 1998)|April 4, 2009
Prasugrel for arterial coronary thrombosisVictor Serebruany, Leonid MakarovJournal of Thrombosis and Thrombolysis|December 23, 1999
Crossreactivity of Human versus Swine Platelet Surface Antigens Is Similar for Glycoproteins Ib and IIIa, but Not for the Glycoprotein IIb/IIIa ComplexSerebruany, Ordonez, Yurovsky, et al.Reviews in Cardiovascular Medicine|September 26, 2021
FDA PLATO deaths list challenges aspirin dose-ticagrelor interactionVictor Serebruany, Jean-Francois TanguayThe American Journal of Medicine|March 16, 2019
Ranolazine, ACE Inhibitors, and Angiotensin Receptor BlockersThomas A Marciniak, Victor SerebruanyJournal of Thrombosis and Thrombolysis|December 23, 1999
Survival in Acute Myocardial Infarction Induced by Coronary Ligation: Prognostic Relevance of Certain Hemostatic Factors During the Occlusion PhaseSerebruany, Solomon, Shustov, et al.American Journal of Therapeutics|April 5, 2019
Should We Use Tegaserod for Irritable Bowel Syndrome?Thomas A Marciniak, Victor SerebruanyThe American Journal of Cardiology|January 16, 2007
Assessment of bleeding events in clinical trials--proposal of a new classificationVictor L Serebruany, Dan AtarTH Open : Companion Journal to Thrombosis and Haemostasis|November 12, 2021
Infections Deaths in the PLATO TrialVictor Serebruany, Jean-Francois TanguayPageof 31